DK127507B - Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.

Info

Publication number
DK127507B
DK127507B DK25372A DK25372A DK127507B DK 127507 B DK127507 B DK 127507B DK 25372 A DK25372 A DK 25372A DK 25372 A DK25372 A DK 25372A DK 127507 B DK127507 B DK 127507B
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
analogous process
benzodiazepine compounds
Prior art date
Application number
DK25372A
Other languages
Danish (da)
English (en)
Inventor
E Reeder
A Stempel
L Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US240750A external-priority patent/US3340253A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK127507B publication Critical patent/DK127507B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
DK25372A 1962-03-09 1972-01-18 Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf. DK127507B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17855162A 1962-03-09 1962-03-09
US240750A US3340253A (en) 1962-11-28 1962-11-28 Preparation of certain benzodiazepine compounds

Publications (1)

Publication Number Publication Date
DK127507B true DK127507B (da) 1973-11-19

Family

ID=26874429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK25372A DK127507B (da) 1962-03-09 1972-01-18 Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.

Country Status (9)

Country Link
BE (1) BE629227A (enrdf_load_stackoverflow)
CA (1) CA976547A (enrdf_load_stackoverflow)
CH (2) CH442326A (enrdf_load_stackoverflow)
DE (4) DE1545955A1 (enrdf_load_stackoverflow)
DK (1) DK127507B (enrdf_load_stackoverflow)
ES (1) ES285854A1 (enrdf_load_stackoverflow)
GB (2) GB1013900A (enrdf_load_stackoverflow)
NL (3) NL7010711A (enrdf_load_stackoverflow)
SE (2) SE328583B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES405260A1 (es) * 1972-07-28 1975-07-01 Stabilimenti Chim Farmac Riuni Procedimiento para la preparacion de 3-hidroxi-5-aril-7- sustituidos-1, 3-dihidro-2h-1, 4-benzodiacepin-2-onas.
NL173269C (nl) * 1974-04-30 1984-01-02 Ferrer Int Werkwijze voor de bereiding van een geneesmiddel met als werkzaam bestanddeel een 1,4-benzodiazepinederivaat, alsmede werkwijze voor de bereiding van het 1,4-benzodiazepinederivaat.
DE3413592C2 (de) * 1984-04-11 1986-06-05 Dolorgiet GmbH & Co KG, 5205 St Augustin Arzneimittel enthaltend 5-(2-Fluorphenyl)-1,3-dihydro-3-hydroxy-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-on
EP0167920A3 (en) * 1984-06-26 1986-11-05 Merck & Co. Inc. Benzodiazepine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE1545956A1 (de) 1969-11-20
ES285854A1 (es) 1963-08-16
SE328583B (enrdf_load_stackoverflow) 1970-09-21
GB1013229A (en) 1965-12-15
NL289735A (enrdf_load_stackoverflow)
DE1545957A1 (de) 1969-12-11
GB1013900A (en) 1965-12-22
CH457464A (de) 1968-06-15
CH442326A (de) 1967-08-31
BE629227A (fr) 1963-10-21
DE1545955A1 (de) 1969-11-20
NL7010711A (enrdf_load_stackoverflow) 1970-10-26
CA976547A (en) 1975-10-21
SE361174B (enrdf_load_stackoverflow) 1973-10-22
NL7010712A (enrdf_load_stackoverflow) 1970-10-26
DE1445873A1 (de) 1969-04-10

Similar Documents

Publication Publication Date Title
DK108497C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK115999B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK109037C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf.
DK109779C (da) Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf.
DK117000B (da) Fremgangsmåde til fremstilling af substituerede phenylamino-1,3-diazacyclopentener-(2) eller syreadditionssalte heraf.
DK115851B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf.
DK127507B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK115771B (da) Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl) guanidin- eller (3,5-diamino-6-halogenpyrazinamido) guanidin-forbindelser eller syreadditionssalte deraf.
DK104408C (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK105472C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK112449B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK107100C (da) Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK105025C (da) Fremgangsmåde til fremstilling af umættede 9,10-dihydro-10,10,-dimethylanthracenderivater eller syreadditionssalte deraf.
DK106381C (da) Fremgangsmåde til fremstilling af 2-dimethylamino-3,5,6-trimethylpyrazin eller syreadditionssalte heraf.
DK101976C (da) Fremgangsmåde til fremstilling af 1,2,3,4,4a,5,6,10b-octahydro-phenanthridinforbindelser eller syreadditionssalte deraf.
DK120953B (da) Fremgangsmåde til fremstilling af geminataminocarbinoler eller de entantiomere eller syradditionssalte deraf.
DK118667B (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK113651B (da) Fremgangsmåde til fremstilling af 6,11-dihydro-11-(3-alkylaminopropyl)-dibenzo-[b,e]thiepiner eller syreadditionssalte deraf.
DK106911C (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-aryl-1H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK106093C (da) Fremgangsmåde til fremstilling af 2-pyrrolidino-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK108726C (da) Fremgangsmåde til fremstilling af 1,3-dihydro-5-pyridyl-7-trifluormethyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK97033C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK110120C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK99638C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.